Hematology – Active Featured

June 3, 20200

U.S. Armed force says reasonable to expect a coronavirus immunization by year-end

A senior U.S. Armed force antibody scientist said on Tuesday it was reasonable to expect that a coronavirus immunization could be accessible to part

March 9, 20200

The topic of ACCC Immediate Past President Ali McBride PharmD, MS, BPS, BCOP, for his 2019-2020 term was “Collaborate. Educate. Compensate: A Prescri

February 24, 20200

Ruxolitinib may yield clinical upgrades, with moderate unfavorable occasions, among patients with myelofibrosis, as indicated by consequences of a st

February 13, 20200

Peripheral neuropathy (PN) is a typical intricacy of hematologic malignancies. Certain neuropathies might be identified with the basic harm itself, p

February 6, 20200

Paleness — otherwise called iron-poor blood — is a condition that creates when either the blood needs more red platelets or the convergence of hemogl

January 25, 20200

At ASH 2019, they had the respect and benefit to introduce a front‑line investigation of acalabrutinib in patients with constant lymphocytic leukemia

January 23, 20200

Analysts as of late utilized cutting edge sequencing information to portray the scene of neoantigens in 184 patients with various myeloma (MM) and ef

January 18, 20200

Ofatumumab support treatment seems to delay movement free endurance (PFS) in patients with backslid constant lymphocytic leukemia (CLL), as indicated

January 10, 20200

In an investigation distributed in Human Cell, specialists detailed 3 novel hazard factors related with the seriousness of interminable graft‐versus‐

November 22, 20190

Hematology is the study of fringe blood and bone marrow cells so as to analyze different infections of the blood, including leukemias, paleness, and